Skip to main content
. 2010 Nov 15;28(36):5287–5293. doi: 10.1200/JCO.2009.27.0090

Table A2.

Investigation for Potential Nonlinearity in Dose Response, Interaction Between Exposures, Effect of Age at Exposure, Time Elapsed Since Exposure,and Genetic Susceptibility

Exposures Included in the Model by Tumor Type Analysis
Deviance df LRT P
Meningioma
    Null model 127.54 92
    Radiation linear in continuous dose 50.83 91 < .001*
        Plus quadratic in continuous dose 50.82 90 .954
        Plus cubic in continuous dose 50.72 89 .748
        Plus quartic in continuous dose 50.47 88 .618
    Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose 44.87 90 .015
        Plus quadratic in continuous dose of intrathecal methotrexate 43.67 89 .274
        Plus cubic in continuous dose of intrathecal methotrexate 35.48 88 .004
        Plus quartic in continuous dose of intrathecal methotrexate 35.48 87 .931
    Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + modification by genetic susceptibility 44.78 89 .780
    Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + interaction 44.69 89 .676
    Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + modification by age at exposure 44.57 89 .583
    Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + modification by time since exposure 44.19 89 .539
    Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + first primary cancer group 35.02 81 .362
Glioma/PNET
    Null model 81.79 59
    Radiation linear in continuous dose 69.58 58 < .001*
        Plus quadratic in continuous dose 67.12 57 .117
        Plus cubic in continuous dose 65.45 56 .197
        Plus quartic in continuous dose 64.64 55 .367
    Radiation linear in continuous dose + modification by genetic susceptibility 63.77 57 .016
    Radiation linear in continuous dose + modification by age at exposure 65.05 57 .033
    Radiation linear in continuous dose + modification by time since exposure 68.74 57 .359

NOTE. Radiation dosed in Gy; chemotherapeutic drugs dosed in milligrams per meter squared.

Abbreviations: df, degrees of freedom; LRT, likelihood ratio test; PNET, primitive neuroectodermal tumor.

*

LRT P value relative to null model.

LRT P value relative to model with radiation fitted as a linear trend in continuous dose.

LRT P value relative to model with radiation and intrathecal methotrexate each fitted as a linear trend in continuous dose.